Scarica l'app Stockscreener
17.30
0.87%
0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Assessing Tango Therapeutics (TNGX) Valuation After Vopimetostat Progress And New Erasca Collaboration - simplywall.st
Tango Therapeutics (TNGX) Soars 52% on Buy Reco - MSN
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings - Yahoo Finance
Tango Therapeutics Inc (TNGX) Stock News & Articles - 24/7 Wall St.
Mizuho Forecasts Strong Price Appreciation for Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
Stifel raises Tango Therapeutics stock price target on PRMT5 data By Investing.com - Investing.com Nigeria
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX) - Bitget
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds - Insider Monkey
Adam Crystal Sells 20,251 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
Stifel raises Tango Therapeutics stock price target on PRMT5 data - Investing.com India
Insider sale: Tango Therapeutics (TNGX) R&D president sells shares - Stock Titan
X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention - 24/7 Wall St.
Is Erasca (ERAS) Quietly Reframing Its RAS Strategy With Tango’s Dual-Target Trial Collaboration? - Yahoo Finance
Tango Therapeutics (NASDAQ:TNGX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Barclays Global Healthcare Conference - marketscreener.com
Tango Therapeutics (TNGX) Valuation Check After Strong Share Price Momentum And High P/S Multiple - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), McKesson (MCK) and Cybin (HELP) - The Globe and Mail
Tango Therapeutics (NASDAQ:TNGX) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Blue Owl Capital Holdings LP Sells 695,000 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cooper Co (COO) and CAMP4 Therapeutics Corporation (CAMP) - The Globe and Mail
TNGX Stock Hits Record High on Inking Collaboration Deal With ERAS - The Globe and Mail
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Tango Therapeutics (TNGX) Q4 Revenue Collapse To US$0 Reinforces Bearish Volatility Narrative - simplywall.st
New hire gets options on 367,500 Tango Therapeutics shares - Stock Titan
Tango Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX) - Seeking Alpha
Tango Therapeutics (NASDAQ:TNGX) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Tango Therapeutics Stock Jumps 36% to a New High. Here’s What’s Driving the Move - TIKR.com
Wedbush Issues Positive Forecast for Tango Therapeutics (NASDAQ:TNGX) Stock Price - MarketBeat
Tango Therapeutics Stock Surges 36% on Strong Q4 Results, Pipeline Momentum and Cash Runway Extension - International Business Times Australia
Tango Therapeutics (NASDAQ:TNGX) Given New $20.00 Price Target at Guggenheim - MarketBeat
Tango Therapeutics (TNGX) Q4 Loss Narrows to $0.29/Share vs $0.33 Estimate; Shares Surge 23% - AlphaStreet
Tango Therapeutics (NASDAQ:TNGX) Price Target Raised to $27.00 at HC Wainwright - MarketBeat
4 Analysts Have This To Say About Tango Therapeutics - Benzinga
Rafferty Asset Management LLC Purchases New Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights - Sahm
Tango Therapeutics (TNGX) hits all-time high as analyst turns bullish - MSN
Stocks to Watch Right Now: EcoPetrol, Credo, Sable Offshore, and More - Insider Monkey
Tango Therapeutics rallies after oncology drug collaboration with Erasca - Mugglehead Investment Magazine
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish - Insider Monkey
Jefferies raises Tango Therapeutics stock price target on RAS deal By Investing.com - Investing.com UK
Jefferies raises Tango Therapeutics stock price target on RAS deal - Investing.com Nigeria
Best Biotech Stocks To Add to Your WatchlistMarch 5th - MarketBeat
Erasca and Tango Therapeutics Partner to Study ERAS-007 and Vopimetostat Combination for MTAP-Deleted Cancers - geneonline.com
Assessing Tango Therapeutics (TNGX) Valuation After Earnings Update And New Erasca Trial Collaboration - simplywall.st
Tango Therapeutics stock hits 52-week high at $13.66 By Investing.com - Investing.com Australia
Tango rises after Q4 results, clinical pact with Erasca - Seeking Alpha
Tango Therapeutics stock hits 52-week high at $13.66 - Investing.com Nigeria
Tango Therapeutics Shares Rise After Q4 Loss Narrows - marketscreener.com
Stifel reiterates Tango Therapeutics stock Buy rating at $15 By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):